U.S. adults age 26 to 49 and primary care, internal medicine and family medicine physicians who were not Drug Addiction Treatment Act (DATA) 2000 certified.
This Opioid Dependence Study of 1,002 U.S. adults was conducted online by Harris Interactive on behalf of Reckitt Benckiser Pharmaceuticals between January 2 and 7, 2013. The survey of 200 primary care, family practice and internal medicine doctors practicing in the United States, who, at the time of the study, were not certified under the Drug Addiction Treatment Act (DATA) 2000 to treat opioid dependence as part of their practice also was conducted online by Harris Interactive on behalf of Reckitt Benckiser Pharmaceuticals between March 13 and 22, 2013. To ensure the survey results were nationally representative, data for the general population were weighted on income, education, ethnicity, region, age within gender and propensity to be online, while the doctors’ data were weighted on years in practice by gender.
1. The Treatment Episode Data Report. Substance Abuse and Mental Health Services Administration.
Available: http://www.oas.samhsa.gov/2k10/230b/230bPainRelvr2k10Web.pdf. Accessed June 4, 2013.
2. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Substance Abuse and Mental Health Services Administration. NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011.
3. Drugs, Brains, and Behavior: The Science of Addiction. National Institute on Drug Abuse. Available:
http://www.drugabuse.gov/ScienceofAddiction/addiction.html. Accessed June 4, 2013.
4. Doran CM. Pharmacoeconomics. 2008;26(5):371-393; 2. World Health Organization. 2004. Available:
http://www.who.int/substance_abuse/publications/en/PositionPaper_English.pdf. Accessed June 4, 2013.
5. HIPAA Privacy Rule and Public Health. Centers for Disease Control and Prevention. Available:
http://www.cdc.gov/mmwr/preview/mmwrhtml/m2e411a1.htm. Accessed June 4, 2013.